{"id":91454,"date":"2024-10-22T16:33:54","date_gmt":"2024-10-22T19:33:54","guid":{"rendered":"https:\/\/murray.adv.br\/?p=91454"},"modified":"2024-10-22T16:33:57","modified_gmt":"2024-10-22T19:33:57","slug":"ems-hypera-merger-could-spark-new-wave-of-consolidation","status":"publish","type":"post","link":"https:\/\/murray.adv.br\/en\/ems-hypera-merger-could-spark-new-wave-of-consolidation\/","title":{"rendered":"EMS-Hypera merger could spark new wave of consolidation"},"content":{"rendered":"\n
Combination of the two companies could generate revenue of R$16bn and capture a market share of approximately 17% in the laboratory industry<\/em><\/h6>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

10\/22\/2024 <\/p>\n\n\n\n

\n\n\n\n

Negotiations for a merger between EMS and Hypera could mark the start of a second wave of consolidation among Brazilian drugmakers.<\/p>\n\n\n\n

There is an expectation that other groups may accelerate mergers and acquisitions following the announcement of the EMS-Hypera deal on Monday (21), given the potential for combining two companies that together generate revenue of R$16 billion and hold a market share of approximately 17%, while typically, pharmaceutical companies do not exceed a 10% market share.<\/p>\n\n\n\n

The economies of scale are significant. The combined company, for example, would gain negotiating power with distributors and pharmacies, a factor that is likely to drive business growth.<\/p>\n\n\n\n

However, industry sources remain skeptical about the feasibility of advancing the deal.<\/p>\n\n\n\n

The view of experts consulted by Valor is that it is not straightforward to approve a transaction stemming from a hostile bid. In addition to the largest shareholder of Hypera, Jo\u00e3o Alves de Queiroz Filho, known as J\u00fanior, having previously rejected merging the businesses because he does not want to become a minority stakeholder in the combined entity, he also holds a significant 21.38% share, which presents challenges for widespread acceptance, one person noted.<\/p>\n\n\n\n

Another person familiar with the matter pointed out that it is rare for a hostile offer from a privately held company to succeed, as the board of directors of the target rival may require extensive due diligence on the numbers presented by the bidder to feel comfortable recommending the deal.<\/p>\n\n\n\n

One source mentioned that EMS is attempting to mobilize Hypera\u2019s investors by making a hostile offer, effectively pressuring them to accept the deal. However, a potential side effect could be attracting new interest in Hypera, as all players in this industry are eyeing potential M&A deals. If this occurs, the interested company could approach Mr. Queiroz Filho and attempt to negotiate amicably.<\/p>\n\n\n\n

To illustrate the potential transaction between EMS and Hypera, they rank first and third, respectively, in the generic-drug market considering Neo Qu\u00edmica, a division of Hypera. This segment generated approximately R$29.2 billion in the 12 months ending in September, according to industry association Sindusfarma, based on data from consulting firm IQVIA.<\/p>\n\n\n\n

Hypera boasts a large portfolio of over-the-counter medications with well-known brands such as Neosaldina, Rinossoro, Lisador, and Coristina. The OTC segment reported revenue of R$21.3 billion.<\/p>\n\n\n\n

For an industry expert, pharmaceutical companies that do not manage to merge are likely to drive prices down, opting to reduce margins rather than lose market share. The pharmaceutical industry generates approximately R$200 billion in revenue.<\/p>\n\n\n\n

Rafael Freixo, director of LEK Consulting, said if completed, the deal would be the largest transaction in the sector in recent years. \u201cThis new company would dominate several product categories. Hypera has a very strong business in over-the-counter medications. It also has a significant presence in the pharmaceutical channel, while EMS is strong in generics and similar products.\u201d<\/p>\n\n\n\n

On Monday, shares of Hypera had an unusual trading day, with transactions reaching R$1.07 billion amid the volatility caused by two announcements that elicited opposite reactions from shareholders. A working capital optimization program negatively impacted market sentiment in the morning until a proposal for a business combination made by EMS shifted the mood in the late afternoon.<\/p>\n\n\n\n

The Hypera\u2019s stock closed the day up 1.9%, at R$26.16. The trading volume of R$1.07 billion was the second-highest on the B3 stock exchange, trailing only Vale, which had R$1.15 billion, and was roughly seven times the R$151 million traded by Hypera on Friday (18).<\/p>\n\n\n\n

Ana Beatriz Bartolo and Felipe Laurence contributed reporting.<\/em><\/p>\n\n\n\n

*By Beth Koike, Fernanda Guimar\u00e3es, Ana Luiza Carvalho \u2014 S\u00e3o Paulo<\/p>\n\n\n\n

Source: Valor Inaternational<\/p>\n\n\n\n

\nhttps:\/\/valorinternational.globo.com\/\n<\/div><\/figure>\n","protected":false},"excerpt":{"rendered":"

Combination of the two companies could generate revenue of R$16bn and capture a market share of approximately 17% in the laboratory industry 10\/22\/2024 Negotiations for a merger between EMS and Hypera could mark the start of a second wave of consolidation among Brazilian drugmakers. There is an expectation that other groups may accelerate mergers and […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8106],"tags":[25562,25563],"class_list":["post-91454","post","type-post","status-publish","format-standard","hentry","category-murray-news","tag-ems-hypera-merger","tag-new-wave-of-consolidation"],"yoast_head":"\nEMS-Hypera merger could spark new wave of consolidation - Murray Advogados<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/murray.adv.br\/en\/ems-hypera-merger-could-spark-new-wave-of-consolidation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EMS-Hypera merger could spark new wave of consolidation - Murray Advogados\" \/>\n<meta property=\"og:description\" content=\"Combination of the two companies could generate revenue of R$16bn and capture a market share of approximately 17% in the laboratory industry 10\/22\/2024 Negotiations for a merger between EMS and Hypera could mark the start of a second wave of consolidation among Brazilian drugmakers. There is an expectation that other groups may accelerate mergers and […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/murray.adv.br\/en\/ems-hypera-merger-could-spark-new-wave-of-consolidation\/\" \/>\n<meta property=\"og:site_name\" content=\"Murray Advogados\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-22T19:33:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-22T19:33:57+00:00\" \/>\n<meta name=\"author\" content=\"Gelcy Bueno\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gelcy Bueno\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/murray.adv.br\/en\/ems-hypera-merger-could-spark-new-wave-of-consolidation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/murray.adv.br\/en\/ems-hypera-merger-could-spark-new-wave-of-consolidation\/\"},\"author\":{\"name\":\"Gelcy Bueno\",\"@id\":\"https:\/\/murray.adv.br\/en\/#\/schema\/person\/dd0d0bea46c2436124555d18c1a0d52e\"},\"headline\":\"EMS-Hypera merger could spark new wave of consolidation\",\"datePublished\":\"2024-10-22T19:33:54+00:00\",\"dateModified\":\"2024-10-22T19:33:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/murray.adv.br\/en\/ems-hypera-merger-could-spark-new-wave-of-consolidation\/\"},\"wordCount\":632,\"keywords\":[\"EMS-Hypera merger\",\"new wave of consolidation\"],\"articleSection\":[\"Murray News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/murray.adv.br\/en\/ems-hypera-merger-could-spark-new-wave-of-consolidation\/\",\"url\":\"https:\/\/murray.adv.br\/en\/ems-hypera-merger-could-spark-new-wave-of-consolidation\/\",\"name\":\"EMS-Hypera merger could spark new wave of consolidation - Murray Advogados\",\"isPartOf\":{\"@id\":\"https:\/\/murray.adv.br\/en\/#website\"},\"datePublished\":\"2024-10-22T19:33:54+00:00\",\"dateModified\":\"2024-10-22T19:33:57+00:00\",\"author\":{\"@id\":\"https:\/\/murray.adv.br\/en\/#\/schema\/person\/dd0d0bea46c2436124555d18c1a0d52e\"},\"breadcrumb\":{\"@id\":\"https:\/\/murray.adv.br\/en\/ems-hypera-merger-could-spark-new-wave-of-consolidation\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/murray.adv.br\/en\/ems-hypera-merger-could-spark-new-wave-of-consolidation\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/murray.adv.br\/en\/ems-hypera-merger-could-spark-new-wave-of-consolidation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/murray.adv.br\/en\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EMS-Hypera merger could spark new wave of consolidation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/murray.adv.br\/en\/#website\",\"url\":\"https:\/\/murray.adv.br\/en\/\",\"name\":\"Murray Advogados\",\"description\":\"PLG International Lawyers\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/murray.adv.br\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/murray.adv.br\/en\/#\/schema\/person\/dd0d0bea46c2436124555d18c1a0d52e\",\"name\":\"Gelcy Bueno\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/murray.adv.br\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1ef2acfe966d6deacdeccd2a24ea89192c41fd05fc60e57b79021358a47f5641?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1ef2acfe966d6deacdeccd2a24ea89192c41fd05fc60e57b79021358a47f5641?s=96&d=mm&r=g\",\"caption\":\"Gelcy Bueno\"},\"url\":\"https:\/\/murray.adv.br\/en\/author\/news\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EMS-Hypera merger could spark new wave of consolidation - Murray Advogados","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/murray.adv.br\/en\/ems-hypera-merger-could-spark-new-wave-of-consolidation\/","og_locale":"en_US","og_type":"article","og_title":"EMS-Hypera merger could spark new wave of consolidation - Murray Advogados","og_description":"Combination of the two companies could generate revenue of R$16bn and capture a market share of approximately 17% in the laboratory industry 10\/22\/2024 Negotiations for a merger between EMS and Hypera could mark the start of a second wave of consolidation among Brazilian drugmakers. There is an expectation that other groups may accelerate mergers and […]","og_url":"https:\/\/murray.adv.br\/en\/ems-hypera-merger-could-spark-new-wave-of-consolidation\/","og_site_name":"Murray Advogados","article_published_time":"2024-10-22T19:33:54+00:00","article_modified_time":"2024-10-22T19:33:57+00:00","author":"Gelcy Bueno","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Gelcy Bueno","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/murray.adv.br\/en\/ems-hypera-merger-could-spark-new-wave-of-consolidation\/#article","isPartOf":{"@id":"https:\/\/murray.adv.br\/en\/ems-hypera-merger-could-spark-new-wave-of-consolidation\/"},"author":{"name":"Gelcy Bueno","@id":"https:\/\/murray.adv.br\/en\/#\/schema\/person\/dd0d0bea46c2436124555d18c1a0d52e"},"headline":"EMS-Hypera merger could spark new wave of consolidation","datePublished":"2024-10-22T19:33:54+00:00","dateModified":"2024-10-22T19:33:57+00:00","mainEntityOfPage":{"@id":"https:\/\/murray.adv.br\/en\/ems-hypera-merger-could-spark-new-wave-of-consolidation\/"},"wordCount":632,"keywords":["EMS-Hypera merger","new wave of consolidation"],"articleSection":["Murray News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/murray.adv.br\/en\/ems-hypera-merger-could-spark-new-wave-of-consolidation\/","url":"https:\/\/murray.adv.br\/en\/ems-hypera-merger-could-spark-new-wave-of-consolidation\/","name":"EMS-Hypera merger could spark new wave of consolidation - Murray Advogados","isPartOf":{"@id":"https:\/\/murray.adv.br\/en\/#website"},"datePublished":"2024-10-22T19:33:54+00:00","dateModified":"2024-10-22T19:33:57+00:00","author":{"@id":"https:\/\/murray.adv.br\/en\/#\/schema\/person\/dd0d0bea46c2436124555d18c1a0d52e"},"breadcrumb":{"@id":"https:\/\/murray.adv.br\/en\/ems-hypera-merger-could-spark-new-wave-of-consolidation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/murray.adv.br\/en\/ems-hypera-merger-could-spark-new-wave-of-consolidation\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/murray.adv.br\/en\/ems-hypera-merger-could-spark-new-wave-of-consolidation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/murray.adv.br\/en\/home\/"},{"@type":"ListItem","position":2,"name":"EMS-Hypera merger could spark new wave of consolidation"}]},{"@type":"WebSite","@id":"https:\/\/murray.adv.br\/en\/#website","url":"https:\/\/murray.adv.br\/en\/","name":"Murray Advogados","description":"PLG International Lawyers","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/murray.adv.br\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/murray.adv.br\/en\/#\/schema\/person\/dd0d0bea46c2436124555d18c1a0d52e","name":"Gelcy Bueno","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/murray.adv.br\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1ef2acfe966d6deacdeccd2a24ea89192c41fd05fc60e57b79021358a47f5641?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1ef2acfe966d6deacdeccd2a24ea89192c41fd05fc60e57b79021358a47f5641?s=96&d=mm&r=g","caption":"Gelcy Bueno"},"url":"https:\/\/murray.adv.br\/en\/author\/news\/"}]}},"_links":{"self":[{"href":"https:\/\/murray.adv.br\/en\/wp-json\/wp\/v2\/posts\/91454","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/murray.adv.br\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/murray.adv.br\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/murray.adv.br\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/murray.adv.br\/en\/wp-json\/wp\/v2\/comments?post=91454"}],"version-history":[{"count":1,"href":"https:\/\/murray.adv.br\/en\/wp-json\/wp\/v2\/posts\/91454\/revisions"}],"predecessor-version":[{"id":91455,"href":"https:\/\/murray.adv.br\/en\/wp-json\/wp\/v2\/posts\/91454\/revisions\/91455"}],"wp:attachment":[{"href":"https:\/\/murray.adv.br\/en\/wp-json\/wp\/v2\/media?parent=91454"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/murray.adv.br\/en\/wp-json\/wp\/v2\/categories?post=91454"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/murray.adv.br\/en\/wp-json\/wp\/v2\/tags?post=91454"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}